Advertisement
Canada markets closed
  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CAD/USD

    0.7316
    -0.0007 (-0.10%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • Bitcoin CAD

    86,586.02
    -1,031.93 (-1.18%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     
  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

Why Canopy Growth Stock Could Double in 2024

Cannabis grows at a commercial farm.
Source: Getty Images

Written by Amy Legate-Wolfe at The Motley Fool Canada

I never thought I would say this again, but Canopy Growth (TSX:WEED) has been on an absolute tear recently. Canopy Growth stock saw its share price surge last week, ending the week up 113% just since March 14!

The reason for the growth could mean that we see Canopy Growth stock double yet again in 2024. So, let’s look at what happened and what it would take to achieve even more.

Government backing

To be clear, the government isn’t backing Canopy Growth stock. However, the president and vice president of the United States have been making some clear moves in support of marijuana legalization. First and foremost, this comes down to the rescheduling of cannabis as a Schedule I narcotic.

ADVERTISEMENT

This scheduling puts it in the same category as something like cocaine, and VP Kamala Harris called this “ridiculous” two weeks ago. Harris called on the Drug Enforcement Administration (DEA) to speed up the rescheduling — to which the DEA stated it was in the process of taking a look.

This comes as the U.S. gets closer and closer to a federal election in November. Marijuana continues to be a hot topic for President Biden; he referenced it in his recent State of the Union address. And with 40 states currently legalizing the product, it shows that he could have an advantage with ongoing support of at least rescheduling the drug.

Germany folds in

While the news out of the U.S. is promising, it’s not exactly federal legalization. However, Canopy Growth stock had even more great news come its way. It was announced that as of April 1, that Germany would recognize marijuana as a non-narcotic. The news marks a “monumental shift in the legal treatment and cultural acceptance of cannabis,” Canopy Growth stock said in a statement.

Canopy Growth stock went on to state that this provides a unique opportunity for the company to expand — not just through the medical avenue but through its commercial presence in the country. This would be through its current Story & Bickel vaporizer brand as well as the current medical offerings.

This legalization is enormous given that Germany continues to hold the largest gross domestic product (GDP) in Europe. With this exposure, Canopy Growth stock could see massive revenue increases in the next year.

What’s next?

There has been a lot of great news in the cannabis industry. However, there hasn’t been much coming from Canopy Growth stock itself. The company sold off a lot of its production properties as well as non-essential businesses over the last few years. This was to reduce costs and pay off debt. And Canopy Growth stock still has a lot of debt on hand.

This adds to its continued miss of earnings estimates, including the latest quarter. However, what investors seem to be more focused on these days is the future. So, should Canopy Growth stock come up with a clear path to profitability from these recent announcements, this could sincerely generate more investor interest.

With all that being said, Canopy Growth stock has already doubled in the last two weeks. So, can the company do it again? Frankly, I believe so — especially with more news like this coming its way.

The post Why Canopy Growth Stock Could Double in 2024 appeared first on The Motley Fool Canada.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Canopy Growth wasn’t one of them. The 10 stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $15,578.55!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 32 percentage points since 2013*.

See the 10 stocks * Returns as of 3/20/24

More reading

Fool contributor Amy Legate-Wolfe owns shares of Canopy Growth Corporation. The Motley Fool has a disclosure policy.

2024